This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: A cluster-randomised controlled trial in The Gambia.

Journal article published in The Lancet Infectious Diseases and co-authored by PATH's Chris Drakeley and Hannah Slater.

Publication date: November 2022

Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: A cluster-randomised controlled trial in The Gambia.

View Resource